Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnist Sam Kirton.

A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary ...

Being diagnosed in January 2017 with idiopathic pulmonary fibrosis (IPF) and learning that the disease is chronic, progressive, and incurable was a lot for one day. Of course, I wanted a cure or ...

In total, 165 IPF patients with chronic cough were randomly assigned to one of three doses of nalbuphine ER (27, 54, or 108 mg) or a placebo, twice daily. The primary goal was to assess the therapy’s ...

Mice lacking let-7 in lung cells spontaneously develop lung injury, demonstrating that the tumor suppressor microRNA serves as a braking mechanism against the formation of profibrotic cells following ...

“Following productive FDA interactions and positive top-line results from the Phase 1b trial, we have designed our RENEW trial to test the promise of our dual mechanism approach to targeting alveolar ...

To find out, a research team led by Victor Thannickal, MD, senior study author and professor of medicine at Tulane, examined gene activity and protein production in lung tissues from IPF patients. The ...

The BEACON-IPF (NCT06097260) trial was assessing whether once-daily doses of bexotegrast (160 mg or 320 mg) could improve lung function in about 360 IPF patients, ages 40 and older, when compared with ...

Fact-checking is important now more than ever This is important to the rare disease community, especially as social media platforms move away from providing fact-checkers to validate information being ...

The IPF treatment’s dose-dependent response in FVC was “particularly” encouraging, said Toby M. Maher, MD, PhD, an investigator in the trial and a professor of clinical medicine at Keck Medicine of ...